Helix BioPharma Corp.: Helix Biopharma Corp. Announces Extension of Early Warrant Exercise Incentive Program and Receipt of Private Placement Subscription

RICHMOND, ON / ACCESSWIRE / April 13, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology

Related Keywords

Canada ,Toronto ,Ontario ,Richmond Hill ,Canadian ,Frank Michalargias ,Toronto Stock Exchange ,Helix Biopharma Corp ,Incentive Program ,Helix Biopharma ,Early Warrant Exercise Incentive Program ,Eligible Warrants ,Incentive Exercise Price ,Extended Warrants ,Warrant Extension ,Anne Mitchell ,Grove Issuer Services ,Jerzy Wilczewski ,Chief Financial ,Looking Statements ,Annual Information Form ,Helix ,Iopharma ,Orp ,Nnounces ,Extension ,Early ,Warrant ,Exercise ,Incentive ,Program ,Receipt ,Private ,Placement ,Subscription ,